Polydatin Ameliorates Staphylococcus Aureus- Induced Mastitis in Mice Via Inhibiting TLR2- Mediated Activation of the P38 MAPK/NF-κB Pathway
Kang-feng Jiang,Gan Zhao,Gan-zhen Deng,Hai-chong Wu,Nan-nan Yin,Xiu-ying Chen,Chang-wei Qiu,Xiu-li Peng
DOI: https://doi.org/10.1038/aps.2016.123
IF: 7.169
2016-01-01
Acta Pharmacologica Sinica
Abstract:Recent studies show that Polydatin (PD) extracted from the roots of Polygonum cuspidatum Sieb, a widely used traditional Chinese remedies, possesses anti-inflammatory activity in several experimental models. In this study, we investigated the anti-inflammatory effects of PD on Staphylococcus aureus -induced mastitis in mice and elucidated the potential mechanisms. In mice with S aureus -induced mastitis, administration of PD (15, 30, 45 mg/kg, ip) or dexamethasone (Dex, 5 mg/kg, ip) significantly suppressed the infiltration of inflammatory cells, ameliorated the mammary structural damage, and inhibited the activity of myeloperoxidase, a biomarker of neutrophils accumulation. Furthermore, PD treatment dose-dependently decreased the levels of TNF-α, IL-1β, IL-6 and IL-8 in the mammary gland tissues. PD treatment also dose-dependently decreased the expression of TLR2, MyD88, IRAK1, IRAK4 and TRAF6 as well as the phosphorylation of TAK1, MKK3/6, p38 MAPK, IκB-α and NF-κB in the mammary gland tissues. In mouse mammary epithelial cells (mMECs) infected by S aureus in vitro , pretreatment with PD dose-dependently suppressed the upregulated pro-inflammatory cytokines and signaling proteins, and the nuclear translocation of NF-κB p65 and AP-1. A TLR2-neutralizing antibody mimicked PD in its suppression on S aureus -induced upregulation of MyD88, p-p38 and p-p65 levels in mMECs. PD (50, 100 μg/mL) affected neither the growth of S aureus in vitro , nor the viability of mMECs. In conclusion, PD does not exhibit antibacterial activity against S aureus , its therapeutic effects in mouse S aureus -induced mastitis depend on its ability to down-regulate pro-inflammatory cytokine levels via inhibiting TLR2-mediated activation of the p38 MAPK/NF-κB signaling pathway.